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Abstract: Aging is a social and economic challenge of the highest importance and a 
multidisciplinary intervention seems to be a promising approach for improving the quality of life 
of elderly individuals. This project was designed aimed at promoting an active and healthy aging 
through the implementation of an intervention program based on the comprehensive geriatric 
assessment model (AGA@4life), focused on promoting health and wellbeing, independence and 
autonomy, mobility, and social inclusion. A non-randomized interventional study was designed to 
evaluate the effect of only a dietetic and nutritional approach (control group (CG)) and the 
combination of a tailored exercise program and a dietetic and nutritional approach (intervention 
group (IG)) in the biochemical and hematological profile of older adults in the framework of 
AGA@4life. The 34 participants enrolled, aged 65 years or over, were subject to a thorough baseline 
(T0) multidisciplinary diagnostic evaluation, including the gathering of clinical information and a 
battery of biochemical and hematological determinations, and reevaluated after eight weeks of 
intervention (T1). Between T0 and T1, an increase in albumin and total proteins serum levels were 
observed in both groups (p < 0.01); the hematological profile in CG and IG showed an increase in 
red cell count and hemoglobin (p < 0.05). In IG, an increase of HDL cholesterol (p < 0.001) and a 
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decrease of triglycerides (p = 0.001) were still observed. The AGA@4life multidisciplinary 
intervention improved the hematological and biochemical profile of old adults, potentially 
contributing to delay the development of several aging comorbidities and increase the quality of life 
of participants. 
Keywords: healthy aging; exercise; prevention; cholesterol; hemoglobin  
 
1. Introduction 
Aging is a physiological process inherent to living beings, influenced by the interaction of multiple 
endogenous and exogenous factors that characterize the adaptive biological response and the genetic 
component [1]. Average life expectancy increased by 5.5 years between 2000 and 2016, with life 
expectancy at birth around 80.9 years in the constituent countries of the European Union and 78.9 years 
in the United States of America [2]. Aging is a social and economic challenge of the highest importance; 
increased life expectancy and declining birth rates are enhancing factors for this demographic 
transformation process, producing new challenges concerning the elderly’s inclusion in society, their 
active life expectancy, their quality of life and the sustainability of health, and social security [3].  
Age is a predictive factor in the development of chronic diseases, such as cardiovascular diseases, 
cancer, stroke, chronic obstructive pulmonary disease, chronic kidney disease, type 2 diabetes, and 
Alzheimer’s, responsible for an increased morbidity, hospitalizations, health costs, and mortality [1,2,4–
6]. Age is also the main risk factor for geriatric syndromes, including fragility and immobility, as well 
as decreased physical resilience [7]. Advanced age contributes to the exacerbation of chronic systemic 
inflammation, oxidative stress, DNA damage, decline of mitochondrial function and cellular 
senescence, thus meeting all the necessary conditions for the onset of metabolic disorders [2,6,7]. 
Fat tissue plays an important role in mechanisms and pathways involved in longevity and 
genesis of age-related diseases, including insulin resistance, cardiovascular disease, type 2 diabetes, 
and osteoporosis. Throughout life, there are major changes in fat distribution and function that affect 
the body's metabolism [8–11]. In addition, advancing age results in the accumulation of adipocytes 
in the bone marrow cavities also, resulting in loss of hematopoietic activity and disorders of bone 
loss. Bone marrow mesenchymal stem cells are responsible for the origin of adipocytes and 
osteoblasts, but with aging they tend to differentiate mostly into adipocytes. Several studies suggest 
that this process results in impairment of osteogenic and hematopoietic activities [8,12]. 
At the biochemical level, with regard to renal function, there is a gradual loss of nephrons, 
decreased enzymatic and metabolic activity of tubular cells, and a higher incidence of pathological 
processes. In addition to this, there is a decrease in drug excretion, the incidence of renal diseases is 
higher, and diseases such as hypertension and diabetes also affect renal function, albeit indirectly. In 
terms of liver function, there is atrophy and a decrease in liver size, as well as decreased function, 
such as protein synthesis. The ability to eliminate substances is also compromised, which can lead to 
drug accumulation [13]. 
Cardiovascular disease remains one of the most important causes of death. The most common 
cause, atherosclerosis, caused by fat deposition in the vascular walls, has progressively developed 
over the years. To assess cardiovascular risk, the lipid profile is generally determined [13]. 
Cholesterol and triglycerides are involved in the process of atherosclerosis and may in the long run 
lead to more serious lesions (thrombosis, ischemia, and infarction) [14]. Hypercholesterolemia is 
quite common in the elderly, and there is a strong relationship between high cholesterol levels and 
the onset of cardiovascular disease [15]. There are several risk factors for increased cholesterol levels, 
including; a high cholesterol and saturated fat diet, which increases low density lipoproteins (LDL) 
cholesterol and triglycerides; common intestinal disorders in the elderly, such as decreased intestinal 
transit which may lead to increased LDL concentration; physical inactivity; frequent metabolic 
disorders, related to high body fat content and insulin resistance that are associated with lipid 
alterations; metabolic syndrome; and diabetes mellitus [14,15]. 
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Aging also leads to changes in the primary lymphoid organs, in which there is infiltration of fat 
in the marrow and atrophy of the thymus, which leads to a reduction in the space allocated to 
hematopoietic cells [16].  
Thus, as aging is associated with the development and appearance of various pathologies, the 
need for a multidisciplinary intervention seems increasingly to be a promising approach for 
improving the quality of life of elderly individuals. To match this cross-cutting issue to the society, a 
project was designed aimed at promoting an active and healthy aging through the implementation 
of an intervention program based on the comprehensive geriatric assessment model (in Portuguese, 
Abordagem Geriátrica Ampla—AGA@4life) [17–20]. The AGA@4life model is currently one of the 
cornerstones in the geriatric approach, being fundamental as a response to the complexity and 
diversity of problems presented by the elderly [21]. 
The AGA@4life program is an intervention program based on an individual, holistic, and 
multidisciplinary assessment protocol, from which intervention strategies will be implemented, 
adjusted to each participant needs, and aimed at preventing frailty and functional, cognitive, and 
social decline of the elderly, supported by differentiated and multidisciplinary technical skills. The 
strategic action of AGA@4life is focused on the valorization of the elderly person, by promoting 
health and wellbeing, independence and autonomy, mobility, and social inclusion [22,23]. 
Combining nutritional education, cognitive stimulation, co-morbidities monitoring, 
physiotherapeutic interventions, therapeutic counseling among others, allows a more diversified and 
effective action in reducing the aggravation of comorbidities in the elderly. Improvements associated 
with this type of intervention, even if not very significant due to the metabolic capacity of the elderly, 
can have a significantly positive impact on improving quality of life and, consequently, reduce 
mortality [22,23]. 
This study aimed to evaluate the impact of the AGA@4life program comprehending a nutritional 
intervention, modifying and correcting dietary errors, while implementing a balanced diet plan 
adjusted to the nutritional needs of each user, as well as evaluate the impact of a tailored exercise 
program in biochemical and hematological parameters in old adults in a day care center.  
2. Material and Methods 
2.1. Design and Population 
The study involved a multidisciplinary team including a physiotherapist, dietitian, physiologist, 
psychologists, audiologists, and biomedical laboratory scientists in order to implement the 
AGA@4life program. 
The AGA@4life program comprised six key steps: (1) Data gathering—diagnostic evaluation of 
the target population; (2) discussion of cases among the multidisciplinary working group; (3) 
definition of an individualized, multidisciplinary intervention plan; (4) implementation of the 
intervention plan, in articulation with the elderly, family members, and caregivers; (5) monitoring 
the response to the intervention plan; (6) revising the intervention according to the results.  
This work consisted in a non-randomized interventional study designed to evaluate the effect 
of a tailored exercise program and a dietetic and nutritional approach in the biochemical and 
hematological profile of older adults in the framework of AGA@4life project. The 34 participants 
enrolled were recruited from a day care centre in Coimbra district, Portugal, and were aged 65 years 
or over, were of female and male genders, were physically autonomous, and had no prior history of 
cerebrovascular or neurological disorders. 
A baseline multidisciplinary diagnostic evaluation (T0) of each participant was performed, 
including the gathering of clinical and demographic information, namely data on comorbidities, diet 
and physical activity profile, cardiovascular risk profile, ongoing treatments, functional ability, and 
a battery of biochemical and hematological determinations including: albumin, total proteins, total 
bilirubin, total cholesterol, high density lipoproteins (HDL) cholesterol, LDL cholesterol, glucose, 
creatinine, uric acid, urea, triglycerides, alanine aminotransferase, aspartate aminotransferase, 
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amylase, lactate dehydrogenase, alkaline phosphatase, GGT, creatine kinase, calcium, C-reactive 
protein, and a complete blood count. 
For the determination of blood parameters, we collected 10 ml of peripheral blood by venous 
puncture for serum and plasma EDTA tubes. The biochemical profile was determined by 
spectrophotometry in the chemistry analyzer Prestige 24i (Tokyo Boeky, Tokyo, Japan) with reagents 
from Cormay® (Warsaw, Poland) The total blood count were performed in a hematology analyzer 
Cell-Dyn Sapphire™ (Abbott Laboratories, Santa Clara, CA, USA). All the assays were validated and 
passed the quality control. 
The nutritional intervention included the application of different tools at baseline evaluation and 
after the program implementation, namely the Mini Nutritional Assessment (MNA), validated in 
Portugal, to determine nutritional risk; Food Frequency Questionnaire, validated in Portugal, to 
determine intake history and food frequency; 24-h survey to determine food intake of the last 24 
hours. The anthropometric measures: Height, weight, body mass index (BMI), waist circumference, 
arm circumference, hip waist ratio, and leg circumference; were determined using a non-extensible 
tape measure. Body composition, specifically the fat mass percentage and lean mass percentage were 
determined using bioelectrical impedance analysis (BIA) [24,25]. 
The nutritional intervention consisted in the first phase in the evaluation of the nutritional risk 
of each participant by MNA and anthropometric data collection: BMI, perimeter and lean and fat 
mass; clinical history; food anamnesis. The collected information enabled the calculation of the 
nutritional needs of each user and the elaboration of an individualized dietary plan, taking into 
account the pathologies associated with the clinical history of the user and the anamnesis and 
biochemical parameters, as well as the elaboration of a set of recommendations to correct the main 
dietary errors observed and possible risk factors, such as hypertension, type 2 diabetes mellitus, 
among others. For each day-care user, the appropriate eating plan was delivered and explained 
individually. The implementation of a nutritional intervention also included an audit to the 
production of meals and, according to these results, training was given to those responsible for 
preparing day center meals. This training covered topics such as healthy eating, specific nutritional 
needs for the elderly, awareness of salt reduction, and substitution with aromatic herbs [24,25]. 
At the level of the established meals in the day care center, they were evaluated taking into 
account the proposal of a qualitative assessment tool for menus aimed at the elderly, published in 
March 2017 by the National Program for the Promotion of Healthy Eating. Taking into account these 
guidelines, a new menu plan was drawn up and instituted. A diet manual was developed including 
a set of different types of diets, programmed and typified, with an indication of prohibited and 
allowed foods and confections, that result from the nutritional needs of the different users assisted in 
the center. 
The participants were divided in two groups according to their willingness to integrate the 
exercise program: The control group (CG) without exercise program intervention (n = 16); and the 
intervention group (IG) with outdoor aerobic exercise sessions and an exercise program based on the 
OTAGO and adapted to a technological system with Exergames, in the functioning of older adults 
living in the community (n = 18).  
After the baseline characterization (T0), the CG was encouraged to keep the usual daily routines, 
while the IG was submitted to a tailored exercise plan based on aerobic exercise sessions and on the 
OTAGO incorporated in a technological system (FallSensing) with pressure and inertial sensors, 
feedback, and Exergames for 8 weeks, three times a week, lasting approximately 20 min. This 
program targeted the knee flexors and extensors muscles, hip abductors, ankle dorsi flexor/plantar 
flexor muscles, and balance. The aerobic exercise sessions followed the recommendations of the 
World Health Organization [26] consisting of two sessions per week with the following structure: A 
10-min walk on flat or slightly sloping ground, balance and coordination exercises, and joint 
mobilization exercises with respiratory coordination (total session duration of 1 h). 
After the eight weeks (T1), all the participants that completed the program (n = 18; 12 females, 6 
males; average age 80.2 ± 10.6) were re-assessed, repeating the evaluations performed at the baseline 
evaluation. At the end of the program, the CG was composed of 7 participants and the IG of 11 
Int. J. Environ. Res. Public Health 2020, 17, 718 5 of 12 
participants. During this period, we had some drop outs, namely justified by hospital internments 
and exchange of day center. 
2.2. Statistics 
Statistical analysis was performed using software IBM SPSS® v.24 (National Opinion Research 
Center, Chicago, IL, USA) and GraphPad Prism v. 6.04 (La Jolla, San Diego, CA, USA). 
All continuous results are expressed as a mean ± standard deviation (SD), and to evaluate the 
normality of distribution, the Shapiro–Wilk test was used. The student’s t-test was applied for 
baseline group comparisons when distribution was normal, otherwise the Wilcoxon test was used. 
Differences were considered statistically significant at p value less than 0.05. 
2.3. Ethics 
The study was conducted according to the guidelines of the Declaration of Helsinki and 
approved by the Ethics Committee of the Polytechnic Institute of Coimbra (approval 8/2018). The 
anonymity and confidentiality of the collected data were guaranteed and all participants signed an 
informed consent prior to the study. There is no conflict of interest to be declared. 
3. Results 
The participants that completed the AGA@4life program (n = 18; 12 females, 6 males; average 
age 80.2 ± 10.6) from the two groups; the CG (n = 7) and IG (n = 11); were evaluated in the different 
moments (T0 and T1) for biochemical and hematological parameters, and the differences between the 
two moments and groups were analyzed by statistical tests. 
The impact of dietetic and nutritional intervention on biochemical parameters is described in 
Table 1. The data show the evolution of the different biochemical parameters in CG between T0 and 
T1, demonstrating significant differences; namely, an increase in albumin, with 4.16 ± 0.37 g/dL in T0 
and 4.43 ± 0.37 in T1 (p = 0.002), and in total proteins, with 6.71 ± 0.41 in T0 and 6.99 ± 0.36 (p = 0.003)  
(Figure 1). The calcium levels also showed a slight reduction from 8.80 ± 0.36 to 8.49 ± 0.41 mg/dL, 
however, remained within the recommended reference values (8–11 mg/dL). The evaluation of 
enzyme activities, renal function, and lipid profiles did not present statistically significant alterations. 
 
Figure 1. Albumin and total protein serum levels in the control group (CG) and intervention group 
(IG) at T0 and T1 moments (** p < 0.01; *** p < 0.001). 
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Table 1. Biochemical parameters measured in CG and IG at moments T0 and T1, presented in medium 
values ± standard deviation and respective reference range values. 
Parameters Units 
CG (n = 7) IG (n = 11) Reference Values 
T0 T1 p T0 T1 p Male Female 
Albumin  g/dL 4.16 ± 0.37 4.43 ± 0.37 0.002 4.31 ± 0.25 4.61 ± 0.25 <0.001 3.0–5.0 3.0–5.0 
Total proteins g/dL 6.71 ± 0.41 6.99 ± 0.36 0.003 6.62 ± 0.31 6.93 ± 0.44 0.004 6.0–8.0 6.0–8.0 
Total bilirubin  g/dL 0.51 ± 0.15 0.54 ± 0.14 n.s 0.60 ± 0.30 0.56 ± 0.18 n.s 0.3–1.2 0.3–1.2 
Total 
cholesterol 
mg/dL 
178.90 ± 
55.62 
177.89 ± 
33.97 
n.s 
180.23 ± 
35.18 
181.69 ± 33.98 n.s <200 <200 
HDL 
cholesterol 
mg/dL 
39.86 ± 
10.21 
42.70 ± 
12.67 
n.s 40.11 ± 5.98 46.54 ± 7.03 <0.001 >55 >60 
LDL 
cholesterol 
mg/dL 
130.69 ± 
48.87 
125.22 ± 
27.14 
n.s 
128.95 ± 
33.65 
123.83 ± 33.33 n.s <100 <100 
Glucose mg/dL 
107.81 ± 
39.85 
106.37 ± 
29.35 
n.s 
126.91 ± 
91.63 
121.77 ± 61.56 n.s 74–106 74–106 
Creatinine mg/dL 0.72 ± 0.12 0.77 ± 0.21 n.s 0.77 ± 0.16 0.73 ± 0.12 n.s 0.7–1.3 0.6–1.1 
Uric acid mg/dL 5.79 ± 1.31 6.00 ± 1.48 n.s 5.47 ± 1.76 4.94 ± 1.58 0.022 3.6–7.7 2.5–6.8 
Urea  mg/dL 
41.77 ± 
16.10 
49.84 ± 
24.59 
n.s 55.84 ± 14.30 56.64 ± 12.45 n.s <50 <50 
Triglycerides mg/dL 
125.60 ± 
39.75 
114.77 ± 
18.12 
n.s 
160.49 ± 
62.78 
129.99 ± 61.62 0.001 <200 <200 
Alanine 
aminotransfer
ase  
IU/L 
23.06 ± 
15.70 
23.19 ± 
13.71 
n.s 19.33 ± 5.54 19.51 ± 7.32 n.s <42 <32 
Aspartate 
aminotransfer
ase 
IU/L 
22.40 ± 
12.37 
22.43 ± 
10.12 
n.s 20.78 ± 6.14 19.73 ± 4.93 n.s <37 <31 
Amylase IU/L 
53.59 ± 
14.03 
58.55 ± 
17.74 
n.s 48.04 ± 25.75 70.01 ± 35.99 n.s 28–100 28–100 
Lactate 
dehydrogenas
e 
IU/L 
377.47 ± 
115.74 
373.96 ± 
120.01 
n.s 
361.29 ± 
64.70 
374.38 ± 52.97 n.s 225–450 225–450 
Alkaline 
phosphatase 
IU/L 
116.71 ± 
78.85 
105.71 ± 
58.63 
n.s 65.55 ± 30.03 66.55 ± 21.54 n.s 56–119 53–141 
γ-glutamyl 
transferase 
IU/L 
34.50 ± 
24.72 
32.66 ± 
19.42 
n.s 35.41 ± 35.12 31.43 ± 31.24 n.s <55 <40 
Creatine 
kinase 
IU/L 
86.29 ± 
47.32 
100.97 ± 
45.75 
n.s 87.62 ± 43.87 69.62 ± 29.47 n.s <190 <167 
Calcium mg/dL 8.80 ± 0.36 8.49 ± 0.41 0.020 8.53 ± 0.38 8.36 ± 0.40 n.s 8–11 8–11 
C-reactive 
protein 
mg/L 1.05 ± 1.05 1.19 ± 2.01 n.s 0.25 ± 0.19 0.49 ± 0.83 n.s <5 <5 
n.s.—non statistically significant (p > 0.05). 
The hematological profile (Table 2) also reflected the dietetic and nutrition intervention in CG 
and we observed a statistically significant increase in red cell blood count from 4.40 ± 0.38 to 4.70 ± 
0.47 × 1012/L (p = 0.007) and hemoglobin from 127.3 ± 20.1 to 134.4 ± 22.8 g/L (p = 0.04) between T0 and 
T1, respectively. In CG, we also observed a slight reduction in neutrophils count, from 5.61 ± 1.84 to 
5.35 ± 1.99 (p = 0.016). 
Table 2. Hematological parameters measured in CG and IG at moments T0 and T1, presented in 
medium values ± standard deviation and respective reference range values. 
Paramete
rs  Units 
CG (n = 7) IG (n = 11) 
Reference Values 
[27] 
T0 T1 p T0 T1 p Male Female 
WBC × 109/L 9.17 ± 1.82 9.04 ± 1.84 n.s 5.94 ± 1.01 6.27 ± 1.71 n.s 4–10 4–10 
NEU × 109/L 5.61 ± 1.84 5.35 ± 1.99 0.016 3.58 ± 0.64 4.00 ± 1.29 n.s 2–7 2–7 
LYM × 109/L 2.28 ± 0.84 2.48 ± 1.00 n.s 1.75 ± 0.70 1.63 ± 0.54 n.s 1.0–3.0 1.0–3.0 
MON × 109/L 0.71 ± 0.32 0.67 ± 0.24 n.s 0.43 ± 0.12 0.48 ± 0.17 n.s 0.2–1.0 0.2–1.0 
EOS × 109/L 0.49 ± 0.41 0.49 ± 0.47 n.s 0.13 ± 0.06 0.11 ± 0.06 n.s 0.02–0.5 0.02–0.5 
BAS × 109/L 0.07 ± 0.04 0.06 ± 0.03 n.s 0.05 ± 0.03 0.05 ± 0.03 n.s 0.02–0.1 
0.02–
0.1 
RBCi × 1012/L 4.41 ± 0.41 4.76 ± 0.52 0.005 3.97 ± 0.52 4.31 ± 0.56 0.012 4.5–5.5 3.8–4.8 
RBCo × 1012/L 4.40 ± 0.38 4.70 ± 0.47 0.007 3.98 ± 0.48 4.29 ± 0.54 0.013 4.5–5.5 3.8–4.8 
HGB g/L 127.3 ± 20.1 134.4 ± 22.8 0.040 127.0 ± 18.1 135.6 ± 17.4 0.031 130–170 120–150 
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MCV fL 89.67 ± 7.70 87.47 ± 8.76 n.s 95.75 ± 4.94 94.99 ± 4.69 n.s 80–100 80–100 
RDW % 12.76 ± 1.44 14.23 ± 3.08 n.s 12.20 ± 0.71 12.24 ± 0.91 n.s 11.6–14 11.6–
14 
MCH pg 28.79 ± 3.16 28.23 ± 3.38 n.s 31.98 ± 1.96 31.53 ± 1.68 n.s 27–32 27–32 
MCHC g/L 320,7 ± 10,00 322,3 ± 10.05 n.s 334.5 ± 10.64 331.9 ± 
10.38 
n.s 320–350 320–
350 
HCT L/L 0.3963 ± 0.0548 
0.4166 ± 
0.0655 n.s 
0.3797 ± 
0.0533 
0.4096 ± 
0.06.0 0.025 
0.40–
0.50 
0.36–
0.46 
PLT × 109/L 281.50 ± 110.54 274.04 ± 68.23 n.s 202.49 ± 53.01 
216.31 ± 
47.53 n.s 150–400 
150–
400 
MPV fL 8.07 ± 0.45 8.92 ± 1.17 n.s 8.26 ± 0.86 8.43 ± 0.95 n.s 8.17–9.65 
8.17–
9.65 
PCT % 0.22 ± 0.08 0.24 ± 0.06 n.s 0.17 ± 0.04 0.18 ± 0.04 n.s 0.17–0.29 
0.17–
0.29 
PDW GSD 15.89 ± 0.46 16.23 ± 0.56 n.s 16.23 ± 0.59 16.51 ± 0.60 n.s 
14.7–
17.4 
14.7–
17.4 
WBC—White Blood Cells; NEU—Neutrophils; LYM—Lymphocytes; MON—Monocytes; EOS—
eosinophils; BAS—Basophils; RBCi—Impedance measurement of red blood cells; RBCo—Optical 
measurement of red blood cells; HGB—Hemoglobin; MCV—Mean corpuscular volume; RDW—Red 
cell distribution width; MCH—Mean corpuscular hemoglobin; MCHC—Mean corpuscular 
hemoglobin concentration-; HCT—Hematocrit; PLT—Platelet count; MPV—Mean platelet volume; 
PCT—Plateletcrit; PDW—Platelet distribution width. 
With respect to IG, we observed the joint impact of dietetic and nutritional intervention and 
exercise on biochemical parameters (Table 1). This intervention showed a greater impact on the 
modification of biochemical parameters, namely in lipid profile, with a significant increase of HDL 
cholesterol from 40.11 ± 5.98 at T0 to 46.54 ± 7.03 in T1 (p < 0.001) and a decrease of triglycerides from 
160.49 ± 62.78 at T0 to 129.99 ± 61.62 in T1 (p = 0.001) (Figure 2). The beneficial impact on albumin and 
total protein serum levels was also verified in IG, like in CG, with a significant increase among T0 to 
T1, from 4.31 ± 0.25 to 4.61 ± 0.25 mg/dL (p < 0.001) and 6.62 ± 0.31 to 6.93 ± 0.44 mg/dL (p = 0.004), 
respectively (Figure 1). The uric acid serum levels also showed a small reduction between T0 and T1 
(p = 0.022), from 5.47 ± 1.76 to 4.94 ± 1.58 mg/dL, respectively. 
 
 
Figure 2. HDL cholesterol and triglycerides serum levels in CG and IG at T0 and T1 moments  
(*** p < 0.001). 
In the IG, the combination of dietetic and nutritional intervention and exercise produced similar 
results to CG in relation to hematological profiles (Table 2), with a statistically significant increase 
being observed, between T0 and T1, in red cell blood count from 3.98 ± 0.48 to 4.29 ± 0.54 × 1012/L (p = 
0.013), hemoglobin from 127.0 ± 18.1 to 135.6 ± 17.4 g/L (p = 0.031), and hematocrit from 0.3797 ± 0.0533 
to 0.4096 ± 0.06.0 L/L (p = 0.025). 
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4. Discussion 
The biological, psychological, and social context of the elderly is very specific. Therefore, the 
physiological processes associated with the course of aging are key determinants of the effectiveness 
of any program aimed at promoting an active and healthy person [28,29]. This population is of a 
remarkable complexity, with multi-morbidity as common feature and the coexistence of several 
chronic diseases associated with the insidious loss of functionality and the increased risk of mortality 
[30,31]. Considering the particular features of this target population, it seems clear that any plan or 
action to confront it must rely on an individualized, multidimensional, and interdisciplinary 
approach, which are the basis of AGA@4life program. 
There are several laboratory tests that allow us to evaluate the physiological functions of the 
individuals, enabling us to understand the state of renal, hepatic, cardiac, and hematopoietic 
function. In this work, we evaluated the impact of AGA@4life program on biochemical and 
hematological profiles of the participants [32,33]. 
The impact of dietetic and nutritional interventions on biochemical parameters were observed, 
between the evaluation moments (T0 and T1), with significant increases in the albumin and total 
protein serum levels of the CG participants. These results demonstrate the contribution of adjusted 
institutional feeding that reflects the basic principles of healthy eating, based on the guidelines of 
Mediterranean Food Wheel provided to all individuals. A protein-deficient diet with adjusted 
calories may lead to an important decrease of blood albumin levels, with even more noticeable 
reflexes in body weight reduction. Hepatic albumin synthesis is affected by protein–calorie 
malnutrition; this adjusted nutrient intake is relevant for polysomal aggregation and maintenance of 
cellular RNA levels needed for albumin synthesis [34]. The evaluation on enzyme activities, renal 
function, and lipid profiles did not present statistically significant alterations, indicating that the 
intervention did not cause any disadvantages for the participants. 
With respect to IG, the joint impact of dietetic and nutritional intervention and exercise on 
biochemical parameters showed a greater impact on the modification of lipid profiles, with an 
increase of HDL cholesterol and a remarkable decrease of triglycerides. The c-HDL is a lipoprotein 
capable of transporting cholesterol from peripheral areas to the liver, thus having a protective 
function against CVD and atherosclerosis [35,36]. Increased levels of serum triglycerides are 
associated with a higher percentage of visceral adipose tissue and consequent comorbidities [37–39] 
Atherosclerosis, obesity, and diabetes mellitus type 2 are characterized by high concentrations of 
triglycerides, LDL cholesterol and low HDL cholesterol [37,39,40]. Several studies have increasingly 
described the relevance of regular exercise in health, in the prevention of comorbidities, and even in 
reducing mortality. Exercise benefits include improvements in cognitive and mental health, loss of 
body fat mass, increased lean body mass, and improvements in diabetes and hypertension, among 
others [41–44]. 
The beneficial impact of the intervention on albumin and total protein serum levels was also 
verified in IG and also verified by a reduction in uric acid serum levels. Several studies have observed 
that there is a tendency for uric acid to increase, with a higher incidence in males, and that urea may 
be slightly increased in the elderly due to the inability of the kidneys to excrete it [32,45–47]. The 
AGA@4life program enabled the reduction of uric acid serum levels, however, urea levels were 
slightly elevated as expected in the participants, and its levels did not change with the intervention. 
With respect to liver transaminases, they apparently do not show significant changes with aging, 
and there may only be a slight increase in aspartate aminotransferase [48]. Our study showed that 
both evaluated groups (CG and IG) presented values within reference ranges. However, another 
study states that alanine aminotransferase tend to decrease with age and can be considered a marker 
of aging [26]. Concerning bilirubin serum levels, they are thought to increase slightly due to the 
inability of liver function excrete them [49]. Our participants also presented total bilirubin serum 
levels within the reference range.  
The AGA@4life program also presented significant modifications in hematological parameters 
evaluated. In CG, individuals were found to have a statistically significant improvement in some 
hematological parameters like red cell blood count and hemoglobin. In CG, we also observed a slight 
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reduction in neutrophils count. In the other hematological parameters, we did not observe significant 
changes in CG participants. White blood cell count tends to be normal, however, in the most fragile 
elderly, an increase in neutrophil count and a slight decrease in lymphocyte count may be observed. 
Regarding platelet levels, no significant changes are described [16]. 
In the IG, the association of dietetic and nutritional intervention and exercise produce similar 
results to CG in relation to hematological profiles, being observed a significantly increase, in red cell 
blood counts, hemoglobin, and even more in hematocrit, emphasizing the potential role of exercise 
in this study group. 
Aging leads to changes in the primary lymphoid organs, in which there is infiltration of fat in 
the marrow and atrophy of the thymus, which leads to a reduction in the space allocated to 
hematopoietic cells [16]. Hemoglobin values tend to decrease due to reduced oxygen demand as a 
result of decreased body mass, physical activity, among a number of other factors [50]. With this, 
anemia is present in a small percentage of individuals over 65 years old; but in the elderly living in 
households, the prevalence is much higher. It is usually a mild to moderate normocytic anemia with 
a low reticulocyte index [50,51]. Although not translating to a severe clinical condition, these changes 
affect the quality of life of the geriatric population, being related to the increase in the number of falls, 
depression, slower walking speed, loss of mobility, functional impairment, reduced grip strength, 
worsening of comorbidities, and mortality [16]. 
The authors consider findings to be relevant at the hematological and biochemical levels for the 
improvement of the quality of life in ageing people, however, they emphasize the need to extend the 
intervention program to more day care centers, increase the number of participants, and evaluate 
other geographic locations in order to consolidate the results. 
5. Conclusions 
The AGA@4life program, a multidisciplinary intervention study in older adults, enables the 
improvement of hematological and biochemical profiles of the participants. The joint impact of 
dietetic and nutritional intervention and exercise on biochemical parameters promoted the 
modification of lipid profiles, with an increase in HDL cholesterol and a remarkable decrease in 
triglycerides. At the hematological level, the program enabled the increase of red cell blood counts, 
hemoglobin, and hematocrit values. These improvements at the physiological level potentially 
contribute to delaying the development of several aging comorbidities and increase the quality of life 
of the older people, with a cost reduction for health-care services. 
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